About Office of Patents & Licensing
The Office of Patents and Licensing supports the research programs of the Lindsley F. Kimball Research Institute (LFKRI), a world-renowned Research Institute specializing in Transfusion Medicine research and the development of innovative solutions to illnesses that affect patients worldwide. The Office works with its scientists to identify, protect, and transfer technologies for further development into products and programs that directly benefit patients and the public. Areas of research include:
- Developing manufacturing processes to produce transfusion grade products including uniform units of red blood cells and growing platelets from cord blood stem cells.
- Vaccines and Therapeutics to prevent and treat HIV, Influenza, SARS, MERS and River Blindness.
- Understanding the immune response in Sickle Cell patients to prevent immune-related adverse reactions in patients who require life-saving blood transfusions.
- Development and application of blood group genomics to provide DNA-based blood group determination for patients and donors to further the adoption and utility of personalized precision medicine.
- Providing research reagents for use in serologic blood typing to help identify rare blood groups in patients and donors.
In addition to the research programs highlighted above, the Office of Patents and Licensing has a wide range of technologies available for licensing and/or sponsored research.
Technologies Available for Licensing
- Blood Processing & Transfusion Products
- Therapeutic Approaches to Treating HIV
- Additional Technologies
For information about licensing or sponsored research opportunities contact:
Coordinator, Law Department & Office of Patents and Licensing